BeOne Medicines Ltd. Cost of Revenue 2016-2023 | ONC
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is BeOne Medicines Ltd.'s current cost of revenue?
BeOne Medicines Ltd. (ONC) annual cost of revenue for 2022 was $286.5M, a 73.72% increase from 2021. BeOne Medicines Ltd. cost of revenue for the quarter ending September 30, 2023 was $96.3M.
What was BeOne Medicines Ltd.'s cost of revenue in 2021?
BeOne Medicines Ltd. annual cost of revenue for 2021 was $164.9M, a 133.39% increase from 2020.
What was BeOne Medicines Ltd.'s cost of revenue in 2020?
BeOne Medicines Ltd. annual cost of revenue for 2020 was $70.7M, a 0.75% decline from 2019.
What is BeOne Medicines Ltd.'s 5-year cost of revenue CAGR?
BeOne Medicines Ltd. cost of revenue grew at a compound annual growth rate (CAGR) of 124.94% from FY2017 to FY2022, going from $5.0M to $286.5M over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+124.9%
FY2017
$5.0M
→
FY2022
$286.5M
16171819202122
5 years selected
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →